Skip to main content

Table 3 Risk assessment of serum leptin in study participants

From: Adipocytokines in obese Ghanaian subjects with or without type 2 diabetes

Variable OR p-value 95% CI aOR p-value 95% CI
Diabetics
 Non-diabetics 3.315 < 0.0001 1.918–5.824 3.217 < 0.0001 1.008–6.045
Gender
 Male       
 Female 9.750 < 0.0001 4.461–21.311 9.561 < 0.0001 4.060–24.200
Exercise
 Yes       
 No 1.296 0.466 0.646–2.600 1.245 0.566 0.588–2.636
Viceral fats
 < 9.0       
 > 9.0 0.163 0.090 0.020–1.330 0.223 0.176 0.025–1.962
Family history of DM
 No       
 Yes 0.655 0.211 0.338–1.270 1.018 0.962 0.490–2.114
TCHOL
 3.5–6.5 mmol/L      
 > 6.5 mmol/l 1.453 0.671 0.259–8.157 0.819 0.83 0.132–5.094
TG
 1.7–2.2 mmol/L      
 > 2.2 mmol/l 0.711 0.737 0.098–5.163 1.041 0.97 0.128–6.477
HDL
 1.3–1.5 mmol/L      
 > 1.5 mmol/l 1.835 0.476 0.346–3.739 1.764 0.532 0.298–4.434
LDL
 3.37–4.12 mmol/L      
 > 4.12 mmol/l 0.685 0.428 0.269–1.746 0.418 0.099 0.148–1.179
  1. Risk assessment for serum leptin levels within the study population
  2. Italic results indicate significant relationships
  3. CI confidence interval; OR odd ratio; aOR adjusted odd ratio; TCHOL total cholesterol; TG triglyceride; HDL high density lipoprotein; LDL low density lipoprotein